AsakuraY, NishimuraN, MaezawaK, TerajimaT, KizuJ, ChohnabayashiN. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices. J Aerosol Med Pulm Drug Deliv., 2013; 26:41–45.
2.
NCT01126437. Comparison of tiotropium in the HandiHaler versus the Respimat in chronic obstructive pulmonary disease. 2011. clinicaltrials.gov/ct2/show/NCT01126437
3.
SinghS, LokeYK, EnrightPL, FurbergCD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ, 2011; 342:d3215.
4.
van NoordJA, CornelissenPJ, AumannJL, PlatzJ, MuellerA, FogartyC. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Respir Med, 2009; 103:22–29.
